Application of Green Chemistry in the Active Pharmaceutical Ingredients Manufacturing

被引:0
|
作者
Tonini, Marlon Daniel L. [1 ]
Lopes, Raquel de O. [2 ]
Barbosa, Maria Leticia C. [3 ,4 ]
机构
[1] Hosp Naval Marcilio Dias HNMD, Inst Pesquisas Biomed IPB, Marinha Brasil, BR-20725090 Rio De Janeiro, RJ, Brazil
[2] Marinha Brasil, Lab Farmaceut Marinha LFM, BR-20911291 Rio De Janeiro, RJ, Brazil
[3] Univ Fed Rio de Janeiro, Fac Farm, Dept Farmacos & Med, Lab Sintese Organ & Quim Med LaSOQuiM, BR-21941902 Rio De Janeiro, RJ, Brazil
[4] Univ Fed Juiz de Fora, Fac Farm, Dept Ciencias Farmaceut, BR-36036900 Juiz De Fora, MG, Brazil
关键词
Green chemistry; active pharmaceutical ingredients (API); active pharmaceutical ingredients manufacture; pharmaceutical industry; SILDENAFIL;
D O I
10.21577/1984-6835.20240020
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The application of Green Chemistry principles in the Active Pharmaceutical Ingredients (API) production is extremely important, aiming to minimize or eliminate the generation of toxic substances during the chemical processes, to reduce costs and the negative environmental impact. As the pharmaceutical sector has the purpose of promoting health, it is expected its activities do not result in a significant impact on the environment and human health, so that the adequacy of the processes employed becomes mandatory for its survival and viability. In the development of new drugs, the API's synthesis processes should ideally be elaborated, from the beginning, based on the principles of Green Chemistry, thus avoiding future additional expenses and regulatory difficulties with its alteration. For products registered with the regulatory agency, changing the API's manufacturing process to a more eco-friendly one demands time and financial resources for both the manufacturer and the pharmaceutical industry in order to meet regulatory requirements and ensure quality of the final pharmaceutical product. Despite this, efforts must be made in favor of sustainability and of environmental protection. This article describes the concept and principles of Green Chemistry, the importance of its application in the API manufacturing and exemplifies API's manufacturing processes based on these principles.
引用
收藏
页码:635 / 646
页数:12
相关论文
共 50 条
  • [21] Polymorphism of active pharmaceutical ingredients
    Karpinski, PH
    CHEMICAL ENGINEERING & TECHNOLOGY, 2006, 29 (02) : 233 - 237
  • [22] Current good manufacturing practice design trends in active pharmaceutical ingredients facilities
    Angelucci, LA
    DRUG INFORMATION JOURNAL, 1999, 33 (03): : 739 - 746
  • [23] Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes
    Morris, KR
    Griesser, UJ
    Eckhardt, CJ
    Stowell, JG
    ADVANCED DRUG DELIVERY REVIEWS, 2001, 48 (01) : 91 - 114
  • [24] Synthetic challenges in the development of commercial manufacturing processes for two active pharmaceutical ingredients
    Savage, Scott
    Domagalski, Nathan
    Hobson, Lindsay
    Jones, Scott
    Mack, Brendan
    Qiu, Yuping
    Ramirez, Antonio
    Waltermire, Robert
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [25] Continuous-Flow TechnologyA Tool for the Safe Manufacturing of Active Pharmaceutical Ingredients
    Gutmann, Bernhard
    Cantillo, David
    Kappe, C. Oliver
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2015, 54 (23) : 6688 - 6728
  • [26] Current Good Manufacturing Practice Design Trends in Active Pharmaceutical Ingredients Facilities
    Louis A. Angelucci
    Drug information journal : DIJ / Drug Information Association, 1999, 33 : 739 - 746
  • [27] A RISK-BASED APPROACH TO MANAGING ACTIVE PHARMACEUTICAL INGREDIENTS IN MANUFACTURING EFFLUENT
    Caldwell, Daniel J.
    Mertens, Birgit
    Kappler, Kelly
    Senac, Thomas
    Journel, Romain
    Wilson, Peter
    Meyerhoff, Roger D.
    Parke, Neil J.
    Mastrocco, Frank
    Mattson, Bengt
    Murray-Smith, Richard
    Dolan, David G.
    Straub, Juerg Oliver
    Wiedemann, Michael
    Hartmann, Andreas
    Finan, Douglas S.
    ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2016, 35 (04) : 813 - 822
  • [28] Prequalification of active pharmaceutical ingredients
    WHO EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS, 2015, 992 : 37 - 37
  • [29] Prequalification of active pharmaceutical ingredients
    WHO EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS, 2013, 981 : 29 - 29
  • [30] Impact of continuous flow chemistry in the synthesis of natural products and active pharmaceutical ingredients
    De Souza, Juliana M.
    Galaverna, Renan
    De Souza, Aline A. N.
    Brocksom, Timothy J.
    Pastre, Julio C.
    De Souza, Rodrigo O. M. A.
    De Oliveira, Kleber T.
    ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS, 2018, 90 : 1131 - 1174